S. Chamaret

13.1k total citations · 4 hit papers
37 papers, 9.4k citations indexed

About

S. Chamaret is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, S. Chamaret has authored 37 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 20 papers in Immunology and 11 papers in Infectious Diseases. Recurrent topics in S. Chamaret's work include HIV Research and Treatment (21 papers), T-cell and Retrovirus Studies (12 papers) and Animal Disease Management and Epidemiology (9 papers). S. Chamaret is often cited by papers focused on HIV Research and Treatment (21 papers), T-cell and Retrovirus Studies (12 papers) and Animal Disease Management and Epidemiology (9 papers). S. Chamaret collaborates with scholars based in France, Democratic Republic of the Congo and Portugal. S. Chamaret's co-authors include Luc Montagnier, J Gruest, C. Dauguet, Jean‐Claude Chermann, Françoise Barré‐Sinoussi, M.T. Nugeyre, C. Rouzioux, Willy Rozenbaum, Denise Guétard and David Klatzmann and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

S. Chamaret

36 papers receiving 8.6k citations

Hit Papers

Isolation of a T-Lymphotropic Retrovirus from a Patient a... 1983 2026 1997 2011 1983 1984 1986 1984 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Chamaret France 24 6.6k 4.1k 3.9k 2.3k 1.3k 37 9.4k
Jean‐Claude Chermann France 31 6.0k 0.9× 4.0k 1.0× 4.0k 1.0× 2.2k 1.0× 1.4k 1.0× 110 9.8k
C. Dauguet France 25 4.9k 0.7× 3.3k 0.8× 3.1k 0.8× 2.4k 1.0× 1.5k 1.1× 44 8.2k
J Gruest France 11 5.0k 0.8× 3.1k 0.7× 3.3k 0.8× 1.7k 0.7× 1.1k 0.9× 25 7.4k
Willy Rozenbaum France 43 5.8k 0.9× 5.0k 1.2× 2.7k 0.7× 3.1k 1.4× 1.2k 0.9× 169 11.0k
Jan Desmyter Belgium 52 4.1k 0.6× 4.9k 1.2× 2.3k 0.6× 2.9k 1.3× 2.0k 1.5× 207 10.2k
Mark B. Feinberg United States 53 7.3k 1.1× 3.9k 0.9× 6.4k 1.6× 2.9k 1.3× 2.1k 1.6× 107 12.2k
T M Folks United States 32 6.1k 0.9× 3.4k 0.8× 3.4k 0.9× 1.8k 0.8× 1.8k 1.4× 62 8.0k
Deborah L. Birx United States 51 6.2k 0.9× 4.8k 1.2× 3.5k 0.9× 2.2k 1.0× 1.6k 1.2× 163 10.2k
Jonathan Weber United Kingdom 58 5.4k 0.8× 4.2k 1.0× 4.5k 1.1× 2.1k 0.9× 1.0k 0.8× 216 10.3k
J. Steven McDougal United States 41 5.9k 0.9× 3.6k 0.9× 3.8k 1.0× 2.2k 0.9× 1.5k 1.2× 87 9.4k

Countries citing papers authored by S. Chamaret

Since Specialization
Citations

This map shows the geographic impact of S. Chamaret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chamaret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chamaret more than expected).

Fields of papers citing papers by S. Chamaret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chamaret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chamaret. The network helps show where S. Chamaret may publish in the future.

Co-authorship network of co-authors of S. Chamaret

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chamaret. A scholar is included among the top collaborators of S. Chamaret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chamaret. S. Chamaret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couroucé, Anne, Françis Barin, S. Chamaret, et al.. (1999). Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24. 18(102). 38–44. 12 indexed citations
2.
Prazuck, Thiérry, Jean‐Elie Malkin, Laurent Bélec, et al.. (1999). ‘Brown sugar’ heroin intoxication and improvement of surrogate immunologic markers in HIV infection. Clinical Microbiology and Infection. 5(5). 244–252. 1 indexed citations
4.
Montagnier, Luc, S. Chamaret, Denise Guétard, et al.. (1997). Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology. The Journal of Infectious Diseases. 175(4). 955–999. 39 indexed citations
5.
Charneau, Pierre, Andrew M. Borman, Caroline Quillent, et al.. (1994). Isolation and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group. Virology. 205(1). 247–253. 123 indexed citations
6.
Dormont, Dominique, François D. Boussin, S. Chamaret, et al.. (1992). Clinical and virological aspects of HIV2 infection in rhesus monkeys.. PubMed. 16(5-6). 341–5. 6 indexed citations
7.
Février, Michèle, Florence Boudet, Jean‐Philippe Corre, et al.. (1992). Idiotypic Expression of Anti-gp120 Antibodies in Unrelated Human Immunodeficiency Virus-infected Individuals. Journal of General Virology. 73(10). 2561–2568. 3 indexed citations
8.
Muller, Sylviane, A.G. Laurent-Crawford, Yves Rivière, et al.. (1992). Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS. 6(9). 933–942. 73 indexed citations
9.
Corre, Jean‐Philippe, Michèle Février, Jacques Thèze, Moncef Zouali, & S. Chamaret. (1991). Anti‐idiotypic antibodies to human anti‐gp120 antibodies bind recombinant and cellular human CD4. European Journal of Immunology. 21(3). 743–751. 22 indexed citations
10.
Montagnier, Luc, Denise Guétard, Alain Blanchard, et al.. (1990). [Infectivity inhibition of HIV prototype strains by antibodies directed against a peptide sequence of mycoplasma].. PubMed. 311(12). 425–30. 18 indexed citations
11.
Haas, C, et al.. (1989). [Chronic lymphocyte sialadenitis related to Gougerot-Sjögren syndrome disclosing HIV seropositivity. A case].. PubMed. 140(3). 214–5. 1 indexed citations
12.
Ameisen, Jean‐Claude, Bruno Guy, S. Chamaret, et al.. (1989). Antibodies to the nef Protein and to nef Peptides in HIV-1—Infected Seronegative Individuals. AIDS Research and Human Retroviruses. 5(3). 279–291. 59 indexed citations
13.
Dormont, Dominique, S. Chamaret, Denise Guétard, et al.. (1989). HIV-2 in Rhesus Monkeys: Serological, Virological and Clinical Results. Intervirology. 30(1). 59–65. 43 indexed citations
14.
Weiss, Robin A., Paul R. Clapham, Jonathan Weber, et al.. (1988). HIV-2 antisera cross-neutralize HIV-1. AIDS. 2(2). 95–100. 56 indexed citations
15.
Kroegel, Claus, K.‐H. Meyer zum Büschenfelde, Daniel Vittecoq, et al.. (1987). ROUTES OF HIV-2 TRANSMISSION IN WESTERN EUROPE. The Lancet. 329(8542). 1150–1151. 8 indexed citations
16.
Clavel, François, Kamal Mansinho, S. Chamaret, et al.. (1987). Human Immunodeficiency Virus Type 2 Infection Associated with AIDS in West Africa. New England Journal of Medicine. 316(19). 1180–1185. 220 indexed citations
17.
Bruet, A, et al.. (1987). [HIV-2 virus infection with long incubation period].. PubMed. 16(39). 1981–1981. 1 indexed citations
18.
Georges, A.J., Danièle Meunier, Michel Vohito, et al.. (1985). Antibodies to lav in various population groups of the Central African Republic. Annales de l Institut Pasteur Virologie. 136(4). 323–325. 4 indexed citations
19.
Montagnier, Luc, F Clavel, Bernard Krust, et al.. (1985). Identification and antigenicity of the major envelope glycoprotein of of lymphadenopathy-associated virus. Virology. 144(1). 283–289. 131 indexed citations
20.
Klatzmann, David, Éric Champagne, S. Chamaret, et al.. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312(5996). 767–768. 1992 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026